Pharmacy Oversight: Maldives Food and Drug Authority (MFDA) rolled out tighter rules on medicine import, storage, dispensing, and sales, limiting retail and online/home delivery to MFDA-authorized providers and requiring pharmacy registration with licensing every three years. Medication Safety for Seniors: UK MHRA advised older adults to limit anticholinergic medicines and use the lowest effective dose for the shortest time after a safety review found a small dementia risk can’t be ruled out. Rare Disease Access: Malaysia reported registering 26 rare-disease medicines since 2020, citing orphan-medicine guidelines and expanded funding for diagnosis and treatment. Medicaid Fraud Controls: U.S. HHS Office of Inspector General urged stronger Medicaid managed-care contract language so states get timely provider-fraud referrals. New Cancer Drug Supply Chain: Alembic Pharma won U.S. FDA final approval for generic prucalopride tablets for chronic idiopathic constipation. Global Pharma Moves: GSK plans to close its Stevenage R&D hub and open a major Cambridge center, aiming to cut costs and ramp up late-stage investment. Reproductive Health Access: Planned Parenthood Great Rivers began offering medication abortion in Springfield, Missouri, after a court ruling struck down prior restrictions. Cancer Treatment Infrastructure: UW Health started proton therapy at Eastpark Medical Center for eligible adult patients in a clinical trial. Public Health Funding: WVU Health System pledged $9 million to Monongalia County public health initiatives, including maternal health, screenings, and vaccine support. Regulatory/Quality Alerts: Pakistan’s Sindh Drug Testing Laboratory flagged nine cancer medicines as fake, illegal, unregistered, or substandard.